Vimarsana
Biggest News Aggregation in the World

Anthony Newcombe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anthony Newcombe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anthony Newcombe Today - Breaking & Trending Today

03.03.22 -- 6 Tips To Ensure Your NDA/BLA Is Ready For FDA Review - Vimarsana News

03.03.22 -- 6 Tips To Ensure Your NDA/BLA Is Ready For FDA Review

03/03/22 Pharmaceutical Online Newsletter

Best Practices For Biopharmaceutical Technology Transfer Facility Fit And Process Gap Assessments - Vimarsana News

Best Practices For Biopharmaceutical Technology Transfer Facility Fit And Process Gap Assessments

During the drug discovery journey, technology transfer is an intrinsic part of the successful development, manufacturing, and commercialization of a...

06.10.21 -- Are You Ready For The FDA's "Data Effect" Tsunami? 8 Steps To Prepare - Vimarsana News

06.10.21 -- Are You Ready For The FDA's "Data Effect" Tsunami? 8 Steps To Prepare

06/10/21 Pharmaceutical Online Newsletter

Advance Biotech Grant Program - Is your company eligible for this Merck Award? - Vimarsana News

Advance Biotech Grant Program - Is your company eligible for this Merck Award?

Novel gene therapy company VectorY was announced by Merck as the European winner of its 2021 Advance Biotech Grant Program. Click to read more...

Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies - Vimarsana News

Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies

Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies Targeting muscular and neurodegenerative disorders Amsterdam-based company seeded by Forbion Co-founded by highly experienced gene therapy technology and manufacturing team VectorY, a fully integrated gene therapy company focused on the development of innovative vectorized antibodies for muscular and neurodegenerative disorders, today announces its official launch. The Company has been operational since October 2020 and has established its laboratories and offices at the Amsterdam Science Park in The Ne...